The demand for Lipid-Lowering Agents in Australia & Oceania has been on the rise in recent years.
Customer preferences: The growing awareness of the health risks associated with high cholesterol levels has led to an increase in demand for Lipid-Lowering Agents in Australia & Oceania. Customers are becoming more health-conscious and are seeking out products that can help them maintain healthy cholesterol levels.
Trends in the market: One trend in the Lipid-Lowering Agents market in Australia & Oceania is the growing popularity of natural and herbal remedies. Many customers are turning to natural and herbal supplements as a more natural alternative to prescription medications. Another trend is the increasing availability of over-the-counter Lipid-Lowering Agents in pharmacies and health food stores. This has made it easier for customers to access these products without a prescription.
Local special circumstances: One unique factor that is driving the demand for Lipid-Lowering Agents in Australia & Oceania is the high rate of heart disease in the region. This has led to a greater emphasis on preventative measures, such as maintaining healthy cholesterol levels. Additionally, the region has a large aging population, which is more susceptible to high cholesterol levels.
Underlying macroeconomic factors: The growing demand for Lipid-Lowering Agents in Australia & Oceania is also being driven by underlying macroeconomic factors. The region has experienced steady economic growth in recent years, which has led to an increase in disposable income. This has allowed customers to spend more on healthcare products, including Lipid-Lowering Agents. Additionally, the region has a well-developed healthcare system, which has made it easier for customers to access these products.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
